Cargando…
Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients
The aim of this study was to investigate copy number of ErbB family members (including EGFR, HER2, HER3 and HER4) in a cohort of gliomas and benign meningiomas (control subjects), and explore the associations of their copy number with clinicopathological characteristics and clinical outcomes of glio...
Autores principales: | Liu, Rui, Qu, Yiping, Chen, Lihong, Pu, Jun, Ma, Sharui, Zhang, Xiaozhi, Yang, Qi, Shi, Bingyin, Hou, Peng, Ji, Meiju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696180/ https://www.ncbi.nlm.nih.gov/pubmed/29190914 http://dx.doi.org/10.18632/oncotarget.21228 |
Ejemplares similares
-
ErbB2 copy number gain is associated with adverse outcome in canine mammary carcinoma
por: SAKAI, Kosei, et al.
Publicado: (2021) -
Increased copy number of mitochondrial DNA predicts poor prognosis of esophageal squamous cell carcinoma
por: Li, Heng, et al.
Publicado: (2018) -
Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma
por: Andolfo, Immacolata, et al.
Publicado: (2011) -
Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma
por: Jones, DeAnalisa C., et al.
Publicado: (2018) -
Low copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in early-stage laryngeal cancer patients
por: Dang, Siwen, et al.
Publicado: (2014)